12:00 AM
Jul 22, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Regulus completes follow-on

Regulus Therapeutics Inc. (NASDAQ:RGLS), San Diego, Calif.
Business: Infectious, Cancer, Cardiovascular

Read the full 40 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >